Histopathologic processing of the sentinel lymph node

Seminars in Breast Disease

Volumn 5, Issue 1, 2002, Pages 35-40

  Turner, Roderick R ^a  

^a SAINT JOHN'S HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; EOSIN; HEMATOXYLIN;

ARTICLE; AXILLARY LYMPH NODE; CANCER STAGING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; TECHNIQUE; TREATMENT PLANNING;

EID: 0036092468     PISSN: 10924450     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma
2. Pathologic analysis of sentinel lymph nodes in breast carcinoma
3. Serial sectioning of sentinel nodes in patients with breast cancer. A pilot study
4. Axillary sentinel lymph node examination in breast carcinoma
5. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma. A preliminary study
6. Sentinel node investigation in breast cancer: Detailed analysis of the yield from step sectioning and immunohistochemistry
7. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging
8. Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work-up
9. Evaluation of axillary sentinel lymph node biopsy by immunohistochemistry and multilevel sectioning in patients with breast carcinoma
10. Sentinel lymph node biopsy: Strategies for pathologic examination of the specimen
11. Histopathological workup of sentinel lymph nodes: How much is enough?
12. Computer simulations of lymph node metastasis for optimizing the pathologic examination of sentinel lymph nodes in patients with breast carcinoma
13. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients
14. Caution concerning micrometastatic breast carcinoma in sentinel lymph nodes
15. Pathologic aspects
16. Benign transport of breast epithelium into axillary lymph nodes after biopsy
17. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999
18. Recommendations for processing and reporting of lymph node specimens submitted for evaluation of metastatic disease
19. Submission of lymph node tissue for axillary studies decreases the accuracy of conventional breast cancer axillary node staging
20. Recommendations for handling radioactive specimens obtained by sentinel lymphadenectomy
21. Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer
22. Touch imprint cytological analysis of sentinel lymph nodes for detecting axillary, metastases in patients with breast cancer
23. The potential value of intraoperative imprint cytology of axillary sentinel lymph nodes in breast cancer patients
24. Intraoperative pathoogic evaluation of a breast cancer sentinel lymph node biopsy as a determinant for synchronous axillary lymph node dissection
25. Sentinel node localization in patients with breast cancer
26. Intraoperative examination of the sentinel lymph node for breast carcinoma staging
27. Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer
28. Is routine intraoperative frozen-section examination of sentinel lymph nodes in breast cancer worthwhile?
29. Evaluation of sentinel lymph node imprints in breast cancer: Role of intraoperative cytokeratin immunostaning in breast cancer staging
30. Rapid intraoperative immunostaining for cytokeratin of sentinel lymph nodes in breast cancer
31. Intraoperative examination of axillary sentinel lymph nodes in breast cancer patients
32. Imnunohistochemistry with pancytokeratins improves the sensitivity of sentinel lymph node biopsy in patients with breast cancer
33. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma
34. Therapeutic implications of the sentinel lymph node in breast cancer
35. Pathologic features associated with non sentinel lymph node metastases in patients with metastatic breast cancer in a sentinel lymph node
36. Sentinel lymph node biopsy with metastasis: Can axillary dissection be avoided in some patients with breast cancer?
37. Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy
38. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients
39. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): Why map DCIS?
40. Sentinel lymph node biopsy: Is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?
41. Lymph node metastasis from ductal carcinoma in situ with microinvasion
42. Bone marrow micrometastases in primary breast cancer: Prognostic significance after 6 years follow-up